VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400

被引:196
作者
Young, Arthur P. [1 ]
Schlisio, Susanne [1 ]
Minamishima, Yoji Andrew [1 ]
Zhang, Qing [1 ]
Li, Lianjie [1 ,4 ]
Grisanzio, Chiara [2 ,3 ]
Signoretti, Sabina [2 ,3 ]
Kaelin, William G., Jr. [1 ,4 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[4] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/ncb1699
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Germline von Hippel-Lindau tumour suppressor gene (VHL) mutations cause renal cell carcinomas, haemangioblastomas and phaeochromocytomas in humans(1). Mutations in VHL also occur in sporadic renal cell carcinomas. The protein encoded by VHL, VHL, is part of the ubiquitin ligase that downregulates the heterodimeric transcription factor Hif under well-oxygenated conditions(1). Here we show that acute VHL inactivation causes a senescent-like phenotype in vitro and in vivo. This phenotype was independent of p53 and Hif but dependent on the retinoblastoma protein (Rb) and the SWI2/SNF2 chromatin remodeller p400. Rb activation occurred through a decrease in Skp2 messenger RNA, which resulted in the upregulation of p27 in a Hif-independent fashion. Our results suggest that senescence induced by VHL inactivation is a tumour-suppressive mechanism that must be overcome to develop VHL-associated neoplasias.
引用
收藏
页码:361 / U115
页数:21
相关论文
共 32 条
[1]   Kip1 meets SKP2: new links in cell-cycle control [J].
Amati, B ;
Vlach, J .
NATURE CELL BIOLOGY, 1999, 1 (04) :E91-E93
[2]   Tissue-specific inactivation of p53 tumor suppression in the mouse [J].
Bowman, T ;
Symonds, H ;
Gu, LY ;
Yin, CY ;
Oren, M ;
VanDyke, T .
GENES & DEVELOPMENT, 1996, 10 (07) :826-835
[3]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[4]   The p400 E1A-associated protein is a novel component of the p53→p21 senescence pathway [J].
Chan, HM ;
Narita, M ;
Lowe, SW ;
Livingstone, DM .
GENES & DEVELOPMENT, 2005, 19 (02) :196-201
[5]   Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis [J].
Chen, ZB ;
Trotman, LC ;
Shaffer, D ;
Lin, HK ;
Dotan, ZA ;
Niki, M ;
Koutcher, JA ;
Scher, HI ;
Ludwig, T ;
Gerald, W ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE, 2005, 436 (7051) :725-730
[6]   Tumour biology -: Senescence in premalignant tumours [J].
Collado, M ;
Gil, J ;
Efeyan, A ;
Guerra, C ;
Schuhmacher, AJ ;
Barradas, M ;
Benguría, A ;
Zaballos, A ;
Flores, JM ;
Barbacid, M ;
Beach, D ;
Serrano, M .
NATURE, 2005, 436 (7051) :642-642
[7]   SV40 LARGE TUMOR-ANTIGEN FORMS A SPECIFIC COMPLEX WITH THE PRODUCT OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE [J].
DECAPRIO, JA ;
LUDLOW, JW ;
FIGGE, J ;
SHEW, JY ;
HUANG, CM ;
LEE, WH ;
MARSILIO, E ;
PAUCHA, E ;
LIVINGSTON, DM .
CELL, 1988, 54 (02) :275-283
[8]   DNA-DAMAGE TRIGGERS A PROLONGED P53-DEPENDENT G(1) ARREST AND LONG-TERM INDUCTION OF CIP1 IN NORMAL HUMAN FIBROBLASTS [J].
DI LEONARDO, A ;
LINKE, SP ;
CLARKIN, K ;
WAHL, GM .
GENES & DEVELOPMENT, 1994, 8 (21) :2540-2551
[9]   The p400 complex is an essential E1A transformation target [J].
Fuchs, M ;
Gerber, J ;
Drapkin, R ;
Sif, S ;
Ikura, T ;
Ogryzko, V ;
Lane, WS ;
Nakatani, Y ;
Livingston, DM .
CELL, 2001, 106 (03) :297-307
[10]   Hypoxia inhibits G1/S transition through regulation of p27 expression [J].
Gardner, LB ;
Li, Q ;
Park, MS ;
Flanagan, WM ;
Semenza, GL ;
Dang, CV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (11) :7919-7926